InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
InspireMD (Nasdaq: NSPR) will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025 at 12:30 PM ET. The company, developer of the CGuard Prime carotid stent system, said a live audio webcast and a replay will be available on its Investor Calendar page. Investors can access the event via the provided webcast link and listen live or via the replay on the company website.
InspireMD (Nasdaq: NSPR) parteciperà a una conversazione informale durante la Piper Sandler 37th Annual Healthcare Conference il mercoledì 3 dicembre 2025 alle 12:30 PM ET. L'azienda, sviluppatrice del sistema di stent carotideo CGuard Prime, ha dichiarato che sarà disponibile una trasmissione audio in diretta e una replica sulla pagina del calendario Investitori. Gli investitori possono accedere all'evento tramite il link di webcast fornito e ascoltare in diretta o tramite la replica sul sito dell'azienda.
InspireMD (Nasdaq: NSPR) participará en una conversación informal durante la Piper Sandler 37th Annual Healthcare Conference el miércoles, 3 de diciembre de 2025 a las 12:30 PM ET. La empresa, desarrolladora del sistema de stents carotídeos CGuard Prime, dijo que habrá una transmisión de audio en vivo y una repetición disponibles en la página de Calendario de Inversores. Los inversores pueden acceder al evento a través del enlace de webcast proporcionado y escuchar en vivo o a través de la repetición en el sitio web de la empresa.
InspireMD (나스닥: NSPR) 는 Piper Sandler 37th Annual Healthcare Conference에서 2025년 12월 3일 수요일 동부 표준시 12:30 PM에 열리는 fireside 토론에 참여합니다. 회사는 CGuard Prime carotid stent system의 개발사이며, 생방송 오디오 웹캐스트와 재방송이 투자자 달력 페이지에서 이용 가능하다고 밝혔습니다. 투자자들은 제공된 웹캐스트 링크를 통해 이벤트에 접속해 실시간으로 듣거나 회사 웹사이트의 재방송을 통해 시청할 수 있습니다.
InspireMD (Nasdaq: NSPR) participera à une discussion informelle lors de la Piper Sandler 37th Annual Healthcare Conference le mercredi 3 décembre 2025 à 12 h 30, heure de l'Est. L'entreprise, développeuse du système de stents carotidiens CGuard Prime, a déclaré qu'une diffusion audio en direct et une rediffusion seront disponibles sur sa page du Calendrier des investisseurs. Les investisseurs peuvent accéder à l'événement via le lien de webcast fourni et écouter en direct ou via la rediffusion sur le site de l'entreprise.
InspireMD (Nasdaq: NSPR) wird an einer Fireside-Diskussion bei der Piper Sandler 37th Annual Healthcare Conference am Mittwoch, 3. Dezember 2025 um 12:30 Uhr ET teilnehmen. Das Unternehmen, Entwickler des CGuard Prime carotid stent system, gab an, dass ein Live-Audio-Webcast und eine Wiederholung auf der Investor Calendar-Seite verfügbar sein werden. Investoren können über den bereitgestellten Webcast-Link auf das Event zugreifen und entweder live zuhören oder die Wiederholung auf der Website des Unternehmens ansehen.
InspireMD (ناسداك: NSPR) ستشارك في جلسة حوار جانبية خلال المؤتمر السنوي الثالث والسبعين للرعاية الصحية الذي تنظمه Piper Sandler يوم الأربعاء 3 ديسمبر 2025 الساعة 12:30 ظهرًا بتوقيت شرق الولايات المتحدة. الشركة، المطوّرة لنظام دعامة الشريان السباتي CGuard Prime، قالت إن بثًا صوتيًا مباشرًا وإعادة بث سيكونان متاحين على صفحة تقويم المستثمر. يمكن للمستثمرين الوصول إلى الحدث عبر رابط البث المقدم والاستماع مباشرًا أو عبر إعادة البث على موقع الشركة.
- None.
- None.
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside discussion at the upcoming Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3rd at 12:30 pm Eastern Time (ET).
A live audio webcast and replay of the discussion may be accessed on the “Investor Calendar” section of the company’s website at: https://event.webcasts.com/starthere.jsp?ei=1744172&tp_key=a1a6262ba9
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com
FAQ
When will InspireMD (NSPR) speak at the Piper Sandler 37th Annual Healthcare Conference?
How can investors access the InspireMD (NSPR) webcast for the Piper Sandler conference?
Will there be a replay of the InspireMD (NSPR) fireside discussion on December 3, 2025?
What product will InspireMD (NSPR) highlight at the Piper Sandler conference?
Where is the InspireMD (NSPR) webcast hosted for the December 3, 2025 presentation?
